MSB 4.69% $1.45 mesoblast limited

Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment, page-77

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 517 Posts.
    lightbulb Created with Sketch. 85
    Just to confirm. They don't have to announce the trial before 21 days AFTER the first patient is dosed right? Does anyone have a link to where this is on the FDA website?

    If this is the case we could be at or around the 21 day mark already. The 1/3 readout potentially could come in the next 10-15 days?

    I read this announcement that they have already dosed people.

    https://hotcopper.com.au/data/attachments/2127/2127076-4c2d22d65fe1f11f2c4b5917914e4f22.jpg

    Apologies I would find this info myself but I've spent a bit of time already and I am studying for an exam tomorrow. Appreciate a link to the info if possible?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.